Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C9XF | ISIN: US0906556065 | Ticker-Symbol: 9OF
Frankfurt
03.04.25
15:29 Uhr
1,540 Euro
-0,040
-2,53 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIORESTORATIVE THERAPIES INC Chart 1 Jahr
5-Tage-Chart
BIORESTORATIVE THERAPIES INC 5-Tage-Chart

Aktuelle News zur BIORESTORATIVE THERAPIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.03.BioRestorative Therapies GAAP EPS of -$1.16 beats by $0.07, revenue of $0.4M misses by $0.43M1
27.03.BioRestorative Therapies, Inc. - 8-K, Current Report1
26.03.Earnings Preview For BioRestorative Therapies1
27.02.BioRestorative Therapies, Inc: BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain355- BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting - - IND clearance expands Company's advanced clinical pipeline...
► Artikel lesen
20.02.BioRestorative Therapies, Inc: BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program295- Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions - - Reflects positive preliminary Phase 2 Safety and Efficacy data reported to date - - May also lead...
► Artikel lesen
10.02.BioRestorative Therapies, Inc. - 8-K, Current Report-
05.12.24BioRestorative Therapies, Inc: BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem Metabolic Disease Program139- Covers cGMP manufacturing processes - - Expected to provide protection until April 29, 2040 - MELVILLE, N.Y., Dec. 05, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative",...
► Artikel lesen
14.11.24BioRestorative Therapies GAAP EPS of -$0.132
BIORESTORATIVE THERAPIES Aktie jetzt für 0€ handeln
13.11.24BioRestorative Therapies GAAP EPS of -$0.13 beats by $0.301
13.11.24BioRestorative Therapies, Inc. - 8-K, Current Report-
13.11.24BioRestorative Therapies, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
13.11.24BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function2
13.11.24BioRestorative Therapies, Inc: BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data99- Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints - - Patient reported efficacy outcomes show a material decrease in pain and increase in...
► Artikel lesen
06.11.24BioRestorative Therapies inks new equity deal1
06.11.24BioRestorative Therapies, Inc. - 8-K, Current Report-
06.11.24BioRestorative Therapies, Inc. - 10-K/A, Annual Report-
05.11.24BioRestorative Therapies, Inc: BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health4
13.08.24BioRestorative Therapies, Inc: BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update575MELVILLE, N.Y., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based...
► Artikel lesen
27.06.24BioRestorative Therapies, Inc: BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem Metabolic Disease Program217- Adds to comprehensive patent portfolio underlying novel ThermoStem® technology platform - - Expanding intellectual property estate expected to help drive ThermoStem® licensing opportunities - -...
► Artikel lesen
17.06.24BioRestorative Therapies, Inc: BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c); Reports First Quarter 2024 Financial Results173- Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) -- BioRestorative...
► Artikel lesen
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1